Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5388-5391
2011
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Survey of Antimicrobial Resistance in Clinical Burkholderia pseudomallei Isolates over Two Decades in Northeast Thailand
- Ist Teil von
- Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5388-5391
- Ort / Verlag
- Washington, DC: American Society for Microbiology
- Erscheinungsjahr
- 2011
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- A 21-year survey conducted in northeast Thailand of antimicrobial resistance to parenteral antimicrobial drugs used to treat melioidosis identified 24/4,021 (0.6%) patients with one or more isolates resistant to ceftazidime (n = 8), amoxicillin-clavulanic acid (n = 4), or both drugs (n = 12). Two cases were identified at admission, and the remainder were detected a median of 15 days after starting antimicrobial therapy. Resistance to carbapenem drugs was not detected. These findings support the current prescribing recommendations for melioidosis.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0066-4804eISSN: 1098-6596DOI: 10.1128/AAC.05517-11Titel-ID: cdi_pubmed_primary_21876049
- Format
- –
- Schlagworte
- amoxicillin, Amoxicillin-Potassium Clavulanate Combination - therapeutic use, Anti-Bacterial Agents, Anti-Bacterial Agents - therapeutic use, antibiotic resistance, Antibiotics. Antiinfectious agents. Antiparasitic agents, Biological and medical sciences, Burkholderia pseudomallei, Burkholderia pseudomallei - drug effects, Burkholderia pseudomallei - pathogenicity, carbapenems, Ceftazidime - therapeutic use, clavulanic acid, Drug Resistance, Bacterial, drug therapy, Epidemiology and Surveillance, Humans, Imipenem - therapeutic use, Medical sciences, melioidosis, Melioidosis - drug therapy, multiple drug resistance, patients, Pharmacology. Drug treatments, surveys, Thailand, Thienamycins - therapeutic use